Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ilkogen is a Turkish biotechnology company dedicated to the development and manufacturing of biosimilars and innovative biologics. Established in 2016 and headquartered in Istanbul, the company focuses on addressing unmet medical needs in oncology and autoimmune diseases. Ilkogen utilizes advanced recombinant DNA technology and cell line development to create high-quality, cost-effective therapeutic alternatives. The company operates a state-of-the-art R&D and manufacturing facility within the Istanbul Teknopark, positioning itself as a key player in Turkey's domestic biopharmaceutical industry. Its mission is to reduce healthcare costs and increase patient access to advanced biological therapies through localized production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ILKOGEN.